BOSTON SCI STILL INTERESTED IN GUIDANT, DESPITE SETBACKS
A day after Guidant confirmed that three additional deaths have been attributed
to models of recalled heart defibrillators, the company's potential buyer, Boston
Scientific, said it still believes in the underlying strength of Guidant's businesses.
Indianapolis-based Guidant, whose cardiac rhythm management division is based
in Arden Hills, said a total of seven deaths have been attributed to models
of implantable cardioverter defibrillators that were recalled because of safety